Simvastatin treatment does not protect retinal ganglion cells from degeneration in a rat model of autoimmune optic neuritis

Experimental Neurology

Volumn 193, Issue 1, 2005, Pages 163-171

  Sättler, Muriel B ^a   Diem, Ricarda ^a   Merkler, Doron ^a   Demmer, Iris ^a   Boger, Ina ^a   Stadelmann, Christine ^a   Bähr, Mathias ^a  

^a UNIVERSITY MEDICAL CENTER GÖTTINGEN   (Germany)

Author keywords

Axonal damage; EAE; Electroretinogram; Neuronal apoptosis; Retinal ganglion cells; Simvastatin; Visual evoked potentials

Indexed keywords

MYELIN OLIGODENDROCYTE GLYCOPROTEIN; SIMVASTATIN; STATIN;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; AUTOIMMUNE DISEASE; CELL SURVIVAL; CONTROLLED STUDY; DRUG EFFECT; ELECTROPHYSIOLOGY; FEMALE; NERVE CELL DEGENERATION; NERVE FIBER; NEUROPROTECTION; NONHUMAN; OPTIC NERVE; OPTIC NERVE DISEASE; PRIORITY JOURNAL; RAT; RETINA GANGLION CELL; VISION;

EID: 16244397032     PISSN: 00144886     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.expneurol.2004.12.010     Document Type: Article

References (46)

1. O. Aktas, S. Waiczies, A. Smorodchenko, J. Dorr, B. Seeger, T. Prozorovski, S. Sallach, M. Endres, S. Brocke, R. Nitsch, and F. Zipp Treatment of relapsing paralysis in experimental encephalomyelitis by targeting Th1 cells through atorvastatin J. Exp. Med. 197 2003 725 733
2. S. Amin-Hanjani, N.E. Stagliano, M. Yamada, P.L. Huang, J.K. Liao, and M.A. Moskowitz Mevastatin, an HMG-CoA reductase inhibitor, reduces stroke damage and upregulates endothelial nitric oxide synthase in mice Stroke 32 2001 980 986
3. J.J. Archelos, S.C. Previtali, and H.P. Hartung The role of integrins in immune-mediated diseases of the nervous system Trends Neurosci. 22 1999 30 38
4. W. Brück, T. Kuhlmann, and C. Stadelmann Remyelination in multiple sclerosis J. Neurol. Sci. 206 2003 181 185
5. A. Chaudhuri, P.E. Hallett, and J.A. Parker Aspheric curvatures, refractive indices and chromatic aberration for the rat eye Vision Res. 23 1983 1351 1363
6. J.L. Contreras, C.A. Smyth, G. Bilbao, C.J. Young, J.A. Thompson, and D.E. Eckhoff Simvastatin induces activation of the serine-threonine protein kinase AKT and increases survival of isolated human pancreatic islets Transplantation 74 2002 1063 1069
7. P.K. Coyle, and H.P. Hartung Use of interferon beta in multiple sclerosis: rationale for early treatment and evidence for dose- and frequency-dependent effects on clinical response Mult. Slcer. 8 2002 2 9
8. B. Cucchiara, and S.E. Kasner Use of statins in CNS disorders J. Neurol. Sci. 187 2001 81 89
9. N. De Stefano, P.M. Matthews, M. Filippi, F. Agosta, M. De Luca, M.L. Bartolozzi, and A. Federico Evidence of early cortical atrophy in MS: relevance to white matter changes and disability Neurology 60 2003 1157 1162
10. R. Diem, M. Hobom, K. Maier, R. Weissert, M.K. Storch, R. Meyer, and M. Bähr Methylprednisolone increases neuronal apoptosis during autoimmune CNS inflammation by inhibition of an endogenous neuroprotective pathway J. Neurosci. 23 2003 6993 7000
11. S. Dimmeler, A. Aicher, M. Vasa, C. Mildner-Rihm, K. Adler, M. Tiemann, H. Rutten, S. Fichtlscherer, H. Martin, and A.M. Zeiher HMG-CoA reductase inhibitors (statins) increase endothelial progenitor cells via the PI 3-kinase/Akt pathway J. Clin. Invest. 108 2001 391 397
12. M. Endres, U. Laufs, Z. Huang, T. Nakamura, P. Huang, M.A. Moskowitz, and J.K. Liao Stroke protection by 3-hydroxy-3-methylglutaryl (HMG)-CoA reductase inhibitors mediated by endothelial nitric oxide synthase Proc. Natl. Acad. Sci. U. S. A. 95 1998 8880 8885
13. B. Ferguson, M.K. Matyszak, M.M. Esiri, and V.H. Perry Axonal damage in acute multiple sclerosis lesions Brain 120 1997 393 399
14. D.C. Hess, A.M. Demchuk, L.M. Brass, and F.M. Yatsu HMG-CoA reductase inhibitors (statins): a promising approach to stroke prevention Neurology 54 2000 790 796
15. M. Hobom, M.K. Storch, R. Weissert, K. Maier, A. Radhakrishnan, B. Kramer, M. Bähr, and R. Diem Mechanisms and time course of neuronal degeneration in experimental autoimmune encephalomyelitis Brain Pathol. 14 2004 148 157
16. M. Honjo, H. Tanihara, K. Nishijima, J. Kiryu, Y. Honda, B.Y. Yue, and T. Sawamura Statin inhibits leukocyte-endothelial interaction and prevents neuronal death induced by ischemia-reperfusion injury in the rat retina Arch. Ophthalmol. 120 2002 1707 1713
17. A. Iglesias, J. Bauer, T. Litzenburger, A. Schubart, and C. Linington T- and B-cell responses to myelin oligodendrocyte glycoprotein in experimental autoimmune encephalomyelitis and multiple sclerosis Glia 36 2001 220 234
18. H. Jick, G.L. Zornberg, S.S. Jick, S. Seshadri, and D.A. Drachman Statins and the risk of dementia Lancet 356 2000 1627 1631
19. H. Jurevics, J. Hostettler, E.D. Muse, D.W. Sammond, G.K. Matsushima, A.D. Toews, and P. Morell Cerebroside synthesis as a measure of the rate of remyelination following cuprizone-induced demyelination in brain J. Neurochem. 77 2001 1067 1076
20. P. Kermer, N. Klocker, M. Labes, and M. Bähr Insulin-like growth factor-I protects axotomized rat retinal ganglion cells from secondary death via PI3-K-dependent Akt phosphorylation and inhibition of caspase-3 in vivo J. Neurosci. 20 2000 2 8
21. B. Kornek, M.K. Storch, R. Weissert, E. Wallstroem, A. Stefferl, T. Olsson, C. Linington, M. Schmidbauer, and H. Lassmann Multiple sclerosis and chronic autoimmune encephalomyelitis: a comparative quantitative study of axonal injury in active, inactive, and remyelinated lesions Am. J. Pathol. 157 2000 267 276
22. T. Kumano, T. Mutoh, H. Nakagawa, and M. Kuriyama HMG-CoA reductase inhibitor induces a transient activation of high affinity nerve growth factor receptor, trk, and morphological differentiation with fatal outcome in PC12 cells Brain Res. 859 2000 169 172
23. C. Linington, T. Berger, L. Perry, S. Weerth, D. Hinze-Selch, Y. Zhang, H.C. Lu, H. Lassmann, and H. Wekerle T cells specific for the myelin oligodendrocyte glycoprotein mediate an unusual autoimmune inflammatory response in the central nervous system Eur. J. Immunol. 23 1993 1364 1372
24. J. Llevadot, S. Murasawa, Y. Kureishi, S. Uchida, H. Masuda, A. Kawamoto, K. Walsh, J.M. Isner, and T. Asahara HMG-CoA reductase inhibitor mobilizes bone marrow-derived endothelial progenitor cells J. Clin. Invest. 108 2001 399 405
25. L. Maffei, and A. Fiorentini Electroretinographic responses to alternating gratings before and after section of the optic nerve Science 211 1981 953 955
26. V. Meske, F. Albert, D. Richter, J. Schwarze, and T.G. Ohm Blockade of HMG-CoA reductase activity causes changes in microtubule-stabilizing protein tau via suppression of geranylgeranylpyrophosphate formation: implications for Alzheimer's disease Eur. J. Neurosci. 17 2003 93 102
27. R. Meyer, R. Weissert, R. Diem, M.K. Storch, K.L. de Graaf, B. Kramer, and M. Bähr Acute neuronal apoptosis in a rat model of multiple sclerosis J. Neurosci. 21 2001 6214 6220
28. M. Michikawa, and K. Yanagisawa Apolipoprotein E4 induces neuronal cell death under conditions of suppressed de novo cholesterol synthesis J. Neurosci. Res. 54 1998 58 67
29. M. Michikawa, and K. Yanagisawa Inhibition of cholesterol production but not of nonsterol isoprenoid products induces neuronal cell death J. Neurochem. 72 1999 2278 2285
30. O. Neuhaus, S. Strasser-Fuchs, F. Fazekas, B.C. Kieseier, G. Niederwieser, H.P. Hartung, and J.J. Archelos Statins as immunomodulators: comparison with interferon-beta 1 b in MS Neurology 59 2002 990 997
31. K. Pahan, F.G. Sheikh, A.M. Namboodiri, and I. Singh Lovastatin and phenylacetate inhibit the induction of nitric oxide synthase and cytokines in rat primary astrocytes, microglia, and macrophages J. Clin. Invest. 100 1997 2671 2679
32. P. Sarchielli, O. Presciutti, R. Tarducci, G. Gobbi, A. Alberti, G.P. Pelliccioli, A. Orlacchio, and V. Gallai 1H-MRS in patients with multiple sclerosis undergoing treatment with interferon beta-1a: results of a preliminary study J. Neurol. Neurosurg. Psychiatry 64 1998 204 2012
33. F. Schroeder, A.M. Gallegos, B.P. Atshaves, S.M. Storey, A.L. McIntosh, A.D. Petrescu, H. Huang, O. Starodub, H. Chao, H. Yang, A. Frolov, and A.B. Kier Recent advances in membrane microdomains: rafts, caveolae, and intracellular cholesterol trafficking Exp. Biol. Med. (Maywood) 226 2001 873 890
34. T. Smith, A. Groom, B. Zhu, and L. Turski Autoimmune encephalomyelitis ameliorated by AMPA antagonists Nat. Med. 6 2000 62 66
35. R. Stanislaus, K. Pahan, A.K. Singh, and I. Singh Amelioration of experimental allergic encephalomyelitis in Lewis rats by lovastatin Neurosci. Lett. 269 1999 71 74
36. A. Stefferl, U. Brehm, M. Storch, D. Lambracht-Washington, C. Bourquin, K. Wonigeit, H. Lassmann, and C. Linington Myelin oligodendrocyte glycoprotein induces experimental autoimmune encephalomyelitis in the "resistant" Brown Norway rat: disease susceptibility is determined by MHC and MHC-linked effects on the B cell response J. Immunol. 163 1999 40 49
37. M.K. Storch, A. Stefferl, U. Brehm, R. Weissert, E. Wallstrom, M. Kerschensteiner, T. Olsson, C. Linington, and H. Lassmann Autoimmunity to myelin oligodendrocyte glycoprotein in rats mimics the spectrum of multiple sclerosis pathology Brain Pathol. 8 1998 681 694
38. B.D. Trapp, J. Peterson, R.M. Ransohoff, R. Rudick, S. Mork, and L. Bo Axonal transection in the lesions of multiple sclerosis N. Engl. J. Med. 338 1998 278 285
39. J.E. Vancea, R.B. Campenotb, and D.E. Vancec The synthesis and transport of lipids for axonal growth and nerve regeneration Biochem. Biophys. Acta 1486 2000 84 96
40. T. Vollmer, L. Key, V. Durkalski, W. Tyor, J. Corboy, S. Markovic-Plese, J. Preiningerova, M. Rizzo, and I. Singh Oral simvastatin treatment in relapsing-remitting multiple sclerosis Lancet 363 2004 1607 1608
41. S. Wahrle, P. Das, A.C. Nyborg, C. McLendon, M. Shoji, T. Kawarabayashi, L.H. Younkin, S.G. Younkin, and T.E. Golde Cholesterol-dependent gamma-secretase activity in buoyant cholesterol-rich membrane microdomains Neurobiol. Dis. 9 2002 11 23
42. R. Weissert, E. Wallstrom, M.K. Storch, A. Stefferl, J. Lorentzen, H. Lassmann, C. Linington, and T. Olsson MHC haplotype-dependent regulation of MOG-induced EAE in rats J. Clin. Invest. 102 1998 1265 1273
43. G. Weitz-Schmidt, K. Welzenbach, V. Brinkmann, T. Kamata, J. Kallen, C. Bruns, S. Cottens, Y. Takada, and U. Hommel Statins selectively inhibit leukocyte function antigen-1 by binding to a novel regulatory integrin site Nat. Med. 7 2001 687 692
44. H. Wekerle, K. Kojima, J. Lannes-Vieira, H. Lassmann, and C. Linington Animal models Ann. Neurol. 36 1994 S47 S53 (Suppl.)
45. P. Werner, D. Pitt, and C.S. Raine Multiple sclerosis: altered glutamate homeostasis in lesions correlates with oligodendrocyte and axonal damage Ann. Neurol. 50 2001 169 180
46. S. Youssef, O. Stuve, J.C. Patarroyo, P.J. Ruiz, J.L. Radosevich, E.M. Hur, M. Bravo, D.J. Mitchell, R.A. Sobel, L. Steinman, and S.S. Zamvil The HMG-CoA reductase inhibitor, atorvastatin, promotes a Th2 bias and reverses paralysis in central nervous system autoimmune disease Nature 420 2002 78 84